Quick Takeaways
- Ronald A. DePinho filed SCHEDULE 13G/A for TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA).
- Disclosed ownership: 6.7%.
- Date of event: 30 Sep 2025.
Ronald A. DePinho - 30 Sep 2025 SCHEDULE 13G/A Report for TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA)
- Filing Manager
- Ronald A. DePinho
- Reporting Manager
- Ronald A. DePinho
- Symbol
- CARA
- Shares outstanding
- 9,346,119 shares
- Disclosed Ownership
- 626,190 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Nov 2025, 17:01:12 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 02 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Ronald A. DePinho disclosed 6.7% ownership in TVARDI THERAPEUTICS, INC. Common Stock, par value $0.001 per share (CARA) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 02 Jun 2025.
- Current filing was accepted on 14 Nov 2025, 17:01.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Ronald A. DePinho | 6.7% | 626,190 | 626,190 | 0 | /s/ Ronald A. DePinho | Ronald A. DePinho |